Can fosfomycin be an alternative therapy for infections caused by E. coli harbouring dual resistance: NDM and four-amino acid insertion in PBP3?

por Bakthavatchalam, Yamuna Devi, Shankar, Abirami, Manokaran, Yuvasri, Walia, Kamini, Veeraraghavan, Balaji
Publicado 2023

Synergistic activity of fosfomycin–meropenem and fosfomycin–colistin against carbapenem resistant Klebsiella pneumoniae: an in vitro evidence

por Bakthavatchalam, Yamuna Devi, Shankar, Abirami, Muthuirulandi Sethuvel, Dhiviya Prabaa, Asokan, Kalaiarasi, Kanthan, Kalaiarasi, Veeraraghavan, Balaji
Publicado 2020

In Vitro Activity of Two Cefepime-Based Novel Combinations, Cefepime/Taniborbactam and Cefepime/Zidebactam, against Carbapenemase-Expressing Enterobacterales Collected in India

por Bakthavatchalam, Yamuna Devi, Elangovan, Divyaa, Jaganathan, Subha Vajjiravelu, Subburaju, Nivedhana, Shankar, Abirami, Manokaran, Yuvasri, J., Sudarsana, Devi, Rema, Baveja, Sujata, Devi, Sheela, S., Jayakumar, Bhattacharya, Sanjay, S. M., Rudresh, Yesudhason, Bineshlal, Shetty, Vignesh, Mutreja, Ankur, Manesh, Abi, Varghese, George M., Marwick, Charis A., Parcell, Benjamin J., Gilbert, Ian H., Veeraraghavan, Balaji
Publicado 2023